Matches in Wikidata for { <http://www.wikidata.org/entity/Q37846178> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q37846178 description "article científic" @default.
- Q37846178 description "article scientifique" @default.
- Q37846178 description "articolo scientifico" @default.
- Q37846178 description "artigo científico" @default.
- Q37846178 description "artículu científicu espublizáu en 2010" @default.
- Q37846178 description "bilimsel makale" @default.
- Q37846178 description "scientific article published on 16 December 2010" @default.
- Q37846178 description "vedecký článok" @default.
- Q37846178 description "vetenskaplig artikel" @default.
- Q37846178 description "videnskabelig artikel" @default.
- Q37846178 description "vědecký článek" @default.
- Q37846178 description "wetenschappelijk artikel" @default.
- Q37846178 description "wissenschaftlicher Artikel" @default.
- Q37846178 description "наукова стаття, опублікована в грудні 2010" @default.
- Q37846178 description "научни чланак" @default.
- Q37846178 description "مقالة علمية نشرت في 16 ديسمبر 2010" @default.
- Q37846178 name "Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis" @default.
- Q37846178 name "Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis" @default.
- Q37846178 name "Efficacy of intranasal Bevacizumab" @default.
- Q37846178 type Item @default.
- Q37846178 label "Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis" @default.
- Q37846178 label "Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis" @default.
- Q37846178 label "Efficacy of intranasal Bevacizumab" @default.
- Q37846178 prefLabel "Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis" @default.
- Q37846178 prefLabel "Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis" @default.
- Q37846178 prefLabel "Efficacy of intranasal Bevacizumab" @default.
- Q37846178 P1433 Q37846178-A1E09F5E-DBD8-439A-8C38-D4B24E74881D @default.
- Q37846178 P1476 Q37846178-515752E9-674A-45A6-B75A-A91793204813 @default.
- Q37846178 P2093 Q37846178-129B8A5C-276D-4D87-87CD-636D94569207 @default.
- Q37846178 P2093 Q37846178-D4D7D2B9-5EA7-4829-AD13-A25559678B21 @default.
- Q37846178 P2860 Q37846178-5DAD4C16-E7DD-42A9-A551-7DCE82A3D339 @default.
- Q37846178 P2860 Q37846178-8402EE01-8A8A-4A11-98AA-1A38DAFFCD81 @default.
- Q37846178 P2860 Q37846178-9BD08C0C-2D48-4F31-BAC5-1BDD29A300F7 @default.
- Q37846178 P2860 Q37846178-B196A03D-45C8-4261-808B-B1A0403B66EC @default.
- Q37846178 P2860 Q37846178-BC79B4E3-9305-48AE-9C7C-D91EAFC049F4 @default.
- Q37846178 P2860 Q37846178-D62CD48C-33AD-4B18-895D-39B0DD1984FC @default.
- Q37846178 P2860 Q37846178-E1F75D1D-046F-4399-9342-A2DDD5756270 @default.
- Q37846178 P304 Q37846178-F02C9C15-5A6B-4E63-8B45-7322D7B81615 @default.
- Q37846178 P31 Q37846178-A9B09535-F25A-45D4-BE48-CAB488498A02 @default.
- Q37846178 P356 Q37846178-39FC0B38-280F-4E5F-8C7E-8055455B8FAD @default.
- Q37846178 P407 Q37846178-38066471-7515-44A3-8250-212443AB3367 @default.
- Q37846178 P433 Q37846178-6F4F476A-DEA9-44EA-A89E-0ED7302AE8C4 @default.
- Q37846178 P478 Q37846178-3B72820B-F4F5-40E9-8685-EE86FF00E87A @default.
- Q37846178 P577 Q37846178-470E02B4-734C-496D-8799-3B2012E9D10F @default.
- Q37846178 P698 Q37846178-DBF83B2D-2EA2-4333-A752-C992888A7D28 @default.
- Q37846178 P921 Q37846178-89CA7C72-6088-4F78-8B2C-4936C9909B08 @default.
- Q37846178 P921 Q37846178-B7DC7BDD-72B9-4424-B037-8E70FB677D70 @default.
- Q37846178 P921 Q37846178-F5BBAAEF-63EE-477E-93AA-A2A9DB1A80CB @default.
- Q37846178 P356 LARY.21415 @default.
- Q37846178 P698 21344445 @default.
- Q37846178 P1433 Q15755068 @default.
- Q37846178 P1476 "Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis" @default.
- Q37846178 P2093 "Terence M Davidson" @default.
- Q37846178 P2093 "Tom T Karnezis" @default.
- Q37846178 P2860 Q33405788 @default.
- Q37846178 P2860 Q33897059 @default.
- Q37846178 P2860 Q36951674 @default.
- Q37846178 P2860 Q40819926 @default.
- Q37846178 P2860 Q47807119 @default.
- Q37846178 P2860 Q48323777 @default.
- Q37846178 P2860 Q48906632 @default.
- Q37846178 P304 "636-638" @default.
- Q37846178 P31 Q13442814 @default.
- Q37846178 P356 "10.1002/LARY.21415" @default.
- Q37846178 P407 Q1860 @default.
- Q37846178 P433 "3" @default.
- Q37846178 P478 "121" @default.
- Q37846178 P577 "2010-12-16T00:00:00Z" @default.
- Q37846178 P698 "21344445" @default.
- Q37846178 P921 Q202013 @default.
- Q37846178 P921 Q413299 @default.
- Q37846178 P921 Q776881 @default.